AVROBIO, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.375 USD | -1.08% |
|
+6.20% | +0.74% |
| May. 15 | Avrobio Insider Bought Shares Worth $971,493, According to a Recent SEC Filing | MT |
| May. 09 | AVROBIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVROBIO, INC. | Bio Therapeutic Drugs | -1.44% | +6.20% | +0.74% | +4.58% | -91.50% | 62.36M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AVRO Stock
- Charts AVROBIO, Inc.
- Comparison Chart
